2-((2S,6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-2-fluoro-7-hydroxy-6a,8a,10,10-tetramethyl-4-oxo-2,4,5,6,6a,6b,7,8,8a,8b,11a,12,12a,12b-tetradecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl acetate;(6?,11?,16?)-21-(Acetyloxy)-6-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregn-4-ene-3,20-dione; 6?-Fluoro-16?-hydroxyhydrocortisone 16,17-acetonide 21-acetate; 6?-Fluoro-11?,16?,17,21-tetrahydroxy Cyclic 16,17-acetal with Acetone 21-Acetate;Flurandrenolone Acetate;
Fluocinolone Acetonide EP Impurity G is a fully characterized chemical compound used as a reference standard of API Fluocinolone Acetonide. The standard offered is compliant with regulatory guidelines. Fluocinolone Acetonide EP Impurity G is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 2802-11-1
